Paral Pharma Private Limited
About Paral Pharma Private Limited
Data last updated:
Paral Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017PTC315683. Its GSTIN is 07AAJCP1138L1Z8 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Binod Kumar Nigam and Baby Kumari.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at E/2 175 Groound Floor Shastri Nagar, New Delhi, Delhi, India – 110052.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.41 Lakh, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹22.99 Lakh (net margin -98.2%) and EBITDA of -₹10.61 Lakh (EBITDA margin -45.3%). Revenue has declined at a compounded annual rate (CAGR) of 77% over three years and 60% over five years.
The company has about 6 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.44 Lakh on record. Court records list 11 cases involving the company, including 11 filed by the company; 10 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressE/2 175 Groound Floor Shastri Nagar, New Delhi, Delhi, India – 110052
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Paral Pharma Private Limited
The main business activity of Paral Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Paral Pharma Private Limited FY 2024 filings available
Paral Pharma Private Limited reported revenue of ₹23.41 Lakh (down 98% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Paral Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 60% over five years, including a 98% fall in the latest year. EBITDA fell 147% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Paral Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹10.61 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹22.99 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Paral Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -45.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -98.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Paral Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Paral Pharma Private Limited
Paral Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ashlar Life Sciences Private Limited | ₹23.59 Lakh (FY 2024) | •••• | •••• | 12.0% | •••• | Delhi, India |
| V N Academy Private Limited | ₹23.51 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Kolkata, West Bengal, India |
| Chandel Multi Health Trading Private Limited | ₹23.5 Lakh (FY 2024) | •••• | •••• | -6.0% | •••• | Bhopal, Madhya Pradesh, India |
| Leucas Pharmaceuticals Private Limited | ₹23.44 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Lucknow, Uttar Pradesh, India |
| Glydous Pharmaceuticals Private Limited | ₹23.42 Lakh (FY 2025) | •••• | •••• | -15.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Paral Pharma Private Limited this company | ₹23.41 Lakh (FY 2025) | •••• | •••• | -98.0% | •••• | New Delhi, Delhi, India |
| Akshan Lifesciences Private Limited | ₹23.4 Lakh (FY 2025) | •••• | •••• | 9.0% | •••• | Dhanbad, Jharkhand, India |
| Derma Swift Health Care Private Limited | ₹23.39 Lakh (FY 2025) | •••• | •••• | 51.0% | •••• | New Delhi, Delhi, India |
| Alfa Beta Chemisalts Private Limited | ₹23.31 Lakh (FY 2025) | •••• | •••• | -5.0% | •••• | Mumbai, Maharashtra, India |
| Raytwin Pharmaceutical Private Limited | ₹23.28 Lakh (FY 2025) | •••• | •••• | -8.0% | •••• | Bhiwandi, Maharashtra, India |
| Caveat Pharma Private Limited | ₹23.16 Lakh (FY 2024) | •••• | •••• | 83.0% | •••• | Gurdaspur, Punjab, India |
Peers are the five companies nearest above and the five nearest below Paral Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Paral Pharma Private Limited
Paral Pharma Private Limited is audited by RAVINDRA KUMAR for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAVINDRA KUMAR | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Paral Pharma Private Limited
Paral Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Binod Kumar Nigam | Director | 06 Apr 2017 | 9 Years 6 Months | Current |
| Baby Kumari | Director | 06 Apr 2017 | 9 Years 6 Months | Current |
Ownership and Shareholding of Paral Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Paral Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2022 | Hdfc Bank Limited | ₹9.44 Lakh | Open |
Total charge records: 1 View all charges
Legal Cases of Paral Pharma Private Limited
Paral Pharma Private Limited has 11 court cases on record: 11 filed by Paral Pharma. 10 cases are pending and 1 is disposed. Status as checked between 29 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 0 | 10 |
Cases on record (3 of 11)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Central, Delhi | Cheque dishonour complaint | Filed by the company against Mahadev Pharmaceuticals | Pending |
| District court, Central, Delhi | Criminal case | Filed by the company against an individual | Pending |
| District court, Central, Delhi | Commercial suit | Filed by the company against Mahadev Pharmaceuticals | Disposed |
Full case history
All 11 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Paral Pharma Private Limited
Paral Pharma Private Limited has a workforce of 6 employees as of Mar 11, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Paral Pharma Private Limited
Paral Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Baby Kumari was appointed as Director on 06 Apr 2017.
Credit Ratings, Litigation & Regulatory Alerts for Paral Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Paral Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Paral Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Paral Pharma Private Limited
Paral Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCP1138L1Z8 | Delhi | Active | 27 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Paral Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paral Pharma Private Limited
Paral Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 April 2017 (9+ years old) and is registered under CIN U51909DL2017PTC315683.
Paral Pharma reported revenue of ₹23.41 Lakh for FY 2025 (down 98% YoY).
Paral Pharma has 2 current directors:
- Binod Kumar Nigam - Director
- Baby Kumari - Director
Paral Pharma reported a net loss of ₹22.99 Lakh (net margin -98.2%) and EBITDA of -₹10.61 Lakh (EBITDA margin -45.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Paral Pharma is -77% over three years and -60% over five years. In the latest year (FY 2025) revenue fell 98%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Paral Pharma is 07AAJCP1138L1Z8, registered in Delhi.
The CIN (Corporate Identification Number) of Paral Pharma is U51909DL2017PTC315683. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Paral Pharma has 11 court cases on record: 11 filed by the company. 10 are pending.
Paral Pharma was incorporated on 06 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Paral Pharma by revenue are Ashlar Life Sciences Private Limited, V N Academy Private Limited, Chandel Multi Health Trading Private Limited, Leucas Pharmaceuticals Private Limited, Glydous Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Baby Kumari was appointed as Director on 06 Apr 2017. Binod Kumar Nigam was appointed as Director on 06 Apr 2017.